BMGL — Basel Medical Cashflow Statement
0.000.00%
- $79.91m
- $81.62m
- SG$10.05m
- 70
- 15
- 42
- 37
Annual cashflow statement for Basel Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | 2.39 | 2.13 | 2.4 |
Depreciation | |||
Non-Cash Items | 0.1 | 0.149 | 0.171 |
Other Non-Cash Items | |||
Changes in Working Capital | -0.27 | -0.238 | -0.595 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Accounts Payable | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | 2.79 | 2.6 | 2.51 |
Capital Expenditures | -0.088 | -0.006 | -0.008 |
Purchase of Fixed Assets | |||
Cash from Investing Activities | -0.088 | -0.006 | -0.008 |
Financing Cash Flow Items | -0.765 | -0.599 | 1.16 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | -12.9 | -2.94 | -1.77 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | -10.2 | -0.346 | 0.734 |